Private company
Flagship Ventures Fund IV General Partner LLC
American company, incorporated in Delaware. Summary from the record
Last updated Oct 21, 2026.
Overview
- HeadquartersDE1
Corporate structure
Flagship Ventures Fund IV General Partner LLC sits at the top of its group. 3 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
- Flagship Ventures Fund IV General Partner LLC DE
- Moderna Stake · Cambridge, Massachusetts, United States
- Rubius Therapeutics (United States) Stake · Cambridge, Massachusetts, United States
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (2 companies). Each entity in the chart links to its source.
Filings
23 filings to the SEC since October 2021: 23 other. The latest 20:
- Aug 31, 2026N-PX EDGAR
- Aug 14, 202613F-NT EDGAR
- May 15, 202613F-NT EDGAR
- Feb 17, 202613F-NT EDGAR
- Nov 14, 202513F-NT EDGAR
- Sep 2, 2025N-PX EDGAR
- Aug 14, 202513F-NT EDGAR
- May 15, 202513F-NT EDGAR
- Feb 14, 202513F-NT EDGAR
- Nov 14, 202413F-NT EDGAR
- Sep 3, 2024N-PX EDGAR
- Aug 14, 202413F-NT EDGAR
- May 15, 202413F-NT EDGAR
- Feb 14, 202413F-NT EDGAR
- Nov 14, 202313F-NT EDGAR
- Aug 14, 202313F-NT EDGAR
- May 15, 202313F-NT EDGAR
- Feb 14, 202313F-NT EDGAR
- Nov 14, 202213F-NT EDGAR
- Aug 15, 202213F-NT EDGAR
The 23 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Stakes it holds
Flagship Ventures Fund IV General Partner LLC has told the SEC it owns more than 5% of 2 companies, latest first (Schedules 13D and 13G).
- ModernaSC 13G/A Feb 14, 20222
- Rubius Therapeutics (United States)SC 13G/A Feb 14, 20223
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3